Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 182,192 | 131,212 | 132,590 | 184,506 | 141,368 |
| Marketable Securities | 25,021 | 37,477 | 47,777 | 43,812 | 46,010 |
| Receivables | 150 | 366 | N/A | N/A | N/A |
| Income taxes - deferred | 235 | 1,613 | 3,552 | 5,162 | 10,749 |
| Other current assets | 44,682 | 7,504 | 13,182 | 0 | 0 |
| TOTAL | $258,707 | $182,985 | $202,876 | $236,820 | $206,200 |
| Non-Current Assets | |||||
| PPE Net | 56 | 59 | 30 | 33 | 27 |
| Investments And Advances | 0 | 0 | 0 | 1,015 | 5,134 |
| Other Non-Current Assets | 54,047 | 96,922 | 46,990 | 21,961 | 23,602 |
| TOTAL | $54,103 | $96,981 | $47,020 | $23,009 | $28,763 |
| Total Assets | $312,810 | $279,966 | $249,896 | $259,829 | $234,963 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 504 | 1,074 | 813 | 155 | 471 |
| Accrued Expenses | N/A | N/A | 0 | 22,738 | 69,531 |
| TOTAL | $68,785 | $10,474 | $32,296 | $92,487 | $149,641 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 337,696 | 337,614 | 333,084 | 328,456 | 329,102 |
| TOTAL | $337,696 | $337,614 | $333,084 | $328,456 | $329,102 |
| Total Liabilities | $406,481 | $348,088 | $365,380 | $420,943 | $478,743 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 139,996 | 139,983 | 139,933 | 139,931 | 139,885 |
| Common Shares | 1,398 | 1,398 | 1,397 | 1,397 | 1,397 |
| Retained earnings | 139,118 | 169,634 | 120,226 | 71,651 | -1,851 |
| Other shareholders' equity | -277 | -5,088 | -2,739 | 401 | -8,533 |
| TOTAL | $-93,671 | $-68,122 | $-115,484 | $-161,114 | $-243,780 |
| Total Liabilities And Equity | $312,810 | $279,966 | $249,896 | $259,829 | $234,963 |